During the past decade, Complejo Asistencial Universitario de Salamanca conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 13 clinical trials were completed, i.e. on average, 22% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 12 clinical trials were completed. i.e. 30.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Complejo Asistencial Universitario de Salamanca" #1 sponsor was "Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León" with 8 trials, followed by "Takeda" with 6 trials sponsored, "Genentech, Inc." with 3 trials sponsored, "Grupo Español de Rehabilitación Multimodal" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Asistencial Universitario de Salamanca" #1 collaborator was "Instituto de Investigación Biomédica de Salamanca" with 8 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Apices Soluciones S.L." with 1 trials as a collaborator and "BeiGene, Ltd." with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Complejo Asistencial Universitario de Salamanca" are "Multiple Myeloma" (9 trials), "Leukemia, Myeloid, Acute" (3 trials), "Leukemia, Myelomonocytic, Chronic" (3 trials), "COVID-19" (2 trials) and "Gastric Cancer" (2 trials). Many other conditions were trialed in "Complejo Asistencial Universitario de Salamanca" in a lesser frequency.

Most popular intervention types in "Complejo Asistencial Universitario de Salamanca" are "Drug" (49 trials), "Other" (5 trials), "Procedure" (4 trials), "Device" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Dexamethasone" (5 trials), "Lenalidomide" (5 trials), "Azacitidine" (3 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Asistencial Universitario de Salamanca" are 63 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Complejo Asistencial Universitario de Salamanca". undefined are not yet recruiting, 28 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Complejo Asistencial Universitario de Salamanca, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Asistencial Universitario de Salamanca, 11 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 3 trials that are defined as “Not Applicable".